McKinley Capital Management’s DexCom DXCM Stock Holding History

McKinley Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.03M	Sell	9,083 -51,287	-85%	-$6.48M	0.18%	86
2024 Q1	$8.37M	Sell	60,370 -93	-0.2%	-$11.7K	1.01%	26
2023 Q4	$7.5M	Sell	60,463 -11	-0%	-$1.12K	0.96%	30
2023 Q3	$5.64M	Buy	60,474 +20,194	+50%	+$2.28M	0.79%	40
2023 Q2	$5.18M	Sell	40,280 -5,300	-12%	-$641K	0.69%	50
2023 Q1	$5.3M	Hold	45,580	–	–	0.7%	53
2022 Q4	$5.16M	Buy	45,580 +11,500	+34%	+$1.26M	0.69%	52
2022 Q3	$2.75M	Sell	34,080 -80	-0.2%	-$6.78K	0.37%	91
2022 Q2	$2.55M	Sell	34,160 -61,272	-64%	-$5.59M	0.33%	91
2022 Q1	$12.2M	Buy	95,432 +268	+0.3%	+$29.3K	1.22%	17
2021 Q4	$12.8M	Buy	95,164 +39,204	+70%	+$5.63M	1.14%	19
2021 Q3	$7.65M	Hold	55,960	–	–	0.72%	38
2021 Q2	$5.97M	Hold	55,960	–	–	0.42%	70
2021 Q1	$5.03M	Buy	+55,960	New	+$5.25M	0.38%	75

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

McKinley Capital Management's DXCM Position: Q2 2024 in Review

McKinley Capital Management reduced its DexCom (DXCM) stake by 85% in Q2 2024, selling an estimated $6.48M and leaving 9,083 shares worth $1.03M. The position accounts for 0.18% of the portfolio, ranked #86.

McKinley Capital Management first reported a position in DXCM in Q1 2021 and has held it in 14 quarters since. The position peaked at $12.8M in Q4 2021. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

McKinley Capital Management held 9,083 shares of DexCom worth $1.03M as of Q2 2024.
McKinley Capital Management sold 51,287 DexCom shares in Q2 2024, an estimated $6.48M.
DexCom made up 0.18% of McKinley Capital Management's portfolio in Q2 2024, its #86 holding.
McKinley Capital Management first reported a position in DexCom in Q1 2021 and has held it in 14 quarters since.
McKinley Capital Management's DexCom position peaked at $12.8M in Q4 2021.
999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.